home / stock / bms / bms news


BMS News and Press, Bemis Company Inc.

Stock Information

Company Name: Bemis Company Inc.
Stock Symbol: BMS
Market: NYSE

Menu

BMS BMS Quote BMS Short BMS News BMS Articles BMS Message Board
Get BMS Alerts

News, Short Squeeze, Breakout and More Instantly...

BMS - K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting

K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting PR Newswire Poster to be presented Sunday, December 10, 2023 CAMBRIDGE, Mass. , Dec. 4, 2023 /PRNe...

BMS - 2 of the Safest Dividend Stocks to Hold During a Market Crash

Excellent dividend stocks are great to hold in times of economic downturns. Since the best of the best typically don't suspend -- or even reduce -- their dividend payments regardless of market and economic conditions, the regular and predictable dividend payments can help investors smooth o...

BMS - Global Human Papillomavirus (HPV) Vaccine Market Could Exceed $12 Billion By 2027

Palm Beach, FL – February 10, 2021 – The incidence of cancer is increasing every year and it has been the major factor for the growth of the cancer vaccines market. Healthcare physicians are looking for alternate therapies, due to the huge burden of cancer cases and the side e...

BMS - Better Buy: bluebird bio vs. Exelixis

Exelixis (NASDAQ: EXEL) and bluebird bio (NASDAQ: BLUE) are two biotech companies that have been moving in opposite directions on the stock market this year. While Exelixis has provided healthy gains -- its stock is up by 52.1% year to date -- Bluebird's shares have slid by 35.2% since t...

BMS - Better Buy: Crispr Therapeutics vs. bluebird bio

bluebird bio (NASDAQ: BLUE) is a biotech company that focuses on gene editing. This technology seeks to treat diseases by replacing the defective genes responsible for them with their healthy counterparts. Year to date, shares of Bluebird are down by 33.9%, which is significantly worse than ...

BMS - Medexus Appoints Accomplished Global Pharmaceutical Industry Executive Adele M. Gulfo to its Board of Directors

MONTREAL, June 25, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF), a leading specialty pharmaceutical company with a strong North American commercial platform, announces that Adele M. Gulfo has joine...

BMS - Amcor Finance (USA), Inc. And Bemis Company, Inc. Announce Extension Of Exchange Offers And Consent Solicitations For US$2.2 Billion Of Notes

ZURICH and NEENAH, Wis. , June 5, 2019 /PRNewswire/ -- Amcor Finance ( USA ), Inc. (" AFUI ") and Bemis Company, Inc. (" Bemis ") (NYSE: BMS) today announced the extension of the Expiration Time (as defined below) of the offers to exchange by AFUI and Bemis (each, an " Exchange Offer " ...

BMS - Merger Arbitrage Mondays - Cypress Semiconductor Deal Speculation Confirmed

Merger activity decreased last week with two new deals announced and one pending deal closing. Deal Statistics: New Deals: The acquisition of Total System Services ( TSS ) by Global Payments ( GPN ) for $21.5 billion in an all stock deal. Under the terms of the merger agreement,...

BMS - Dividend Income Update May 2019

The beginning of every month is exciting for all dividend income investors, as we look back at the previous month and see how much passive dividend income our portfolios generated. No doubt, these are the best posts to write and read online, as it only provides further proof that dividend inve...

BMS - Bemis Set to Join S&P 500; Mattel to Join S&P MidCap 400

NEW YORK , June 3, 2019 /PRNewswire/ -- S&P MidCap 400 constituent Bemis Company Inc. (NYSE: BMS) will replace Mattel Inc. (NASD: MAT) in the S&P 500, and Mattel will replace Bemis in the S&P MidCap 400 effective prior to the open of trading on Friday, June 7 . Amcor Limited ...

Next 10